Skip to main content

Table 1 Demographic findings of the patients

From: Accuracy of endoscopic ultrasound-guided fine-needle aspiration in the suspicion of pancreatic metastases

Characteristics

n (%)

Age (average)

60.3y (26–84 y)

Gender (male/female)

26 (70) / 11 (30)

Symptoms

24 (65)

  Abdominal pain

11

  Abdominal pain + weight loss

6

  Jaundice

5

  Acute pancreatitis

2

Asymptomatic

13 (35)

Diagnosis of metastases

 

  Control of disease

29 (78)

   Non-Hodgkin lymphoma

6

   Colon cancer (adenocarcinoma)

4

   Renal cancer (clear renal cell cancer)

4

   Breast cancer

3

   Sarcoma [Leyomiossarcome (1), Rhabdomiossarcome (1) and sarcoma (1)]

3

   Gastric cancer (adenocarcinoma)

2

   Skin cancer (melanoma)

2

   Bladder cancer

1

   Esophageal cancer (squamous cell carcinoma)

1

   Gallbladder cancer

1

   Lung cancer (NSCLG)

1

   Mieloma Multiplus (Plasmocytoma)

1

  Before identification of the primary cancer

6 (15)

   Renal cancer (clear renal cell cancer)

1

   Lung [SCLC(1) and squamous cell carcinoma (2)]

3

   Ovarian cancer

1

   Mesothelyoma

1

  Initial Staging

2 (6)

   Gastric cancer (signet ring cells adenocarcinoma)

1

   Liver (hepatocellular carcinoma)

1

  1. NSCLC: non-small cell lung cancer; SCLG: small cell lung cancer.
  2. Control of disease: periodical control of a previously identified extrapancreatic tumour.
  3. Before identification of the primary cancer: Imaging methods revealed a pancreatic mass, and EUS-FNA confirmed it as a metastatic tumour, without detection of the primary cancer.
  4. Initial staging: an extrapancreatic tumour and a pancreatic mass or enlargement were detected at the same time.
Back to article page

BMC Gastroenterology

ISSN: 1471-230X

Contact us